Companies House true 2025-01-01 2025-12-31 false 15332205 uk-bus:Director1 2025-01-01 2025-12-31 15332205 uk-bus:Director2 2025-01-01 2025-12-31 15332205 2025-01-01 2025-12-31 15332205 2025-12-31 15332205 uk-bus:EntityHasNeverTraded 2025-01-01 2025-12-31 15332205 uk-bus:FRS102 2025-01-01 2025-12-31 15332205 uk-bus:FullAccounts 2025-01-01 2025-12-31 15332205 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 15332205 2024-12-31 15332205 uk-bus:OrdinaryShareClass1 2025-01-01 2025-12-31 15332205 uk-bus:OrdinaryShareClass2 2025-01-01 2025-12-31 15332205 uk-bus:OrdinaryShareClass3 2025-01-01 2025-12-31 15332205 uk-bus:PreferenceShareClass1 2025-01-01 2025-12-31 15332205 uk-bus:PreferenceShareClass2 2025-01-01 2025-12-31 15332205 uk-bus:PreferenceShareClass3 2025-01-01 2025-12-31 15332205 uk-core:ShareCapitalPreferenceShares 2025-12-31 15332205 uk-core:ShareCapitalPreferenceShares 2024-12-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 15332205

TAIWAN OYI PEPTIDE CO., LTD

Dormant Accounts

31 December 2025

TAIWAN OYI PEPTIDE CO., LTD Registered Number 15332205

Balance Sheet as at 31 December 2025

2025 2024
£ £
Called up share capital not paid
5000
5000
Net assets
5000
5000
Issued share capital
5000 Ordinary Shares of £ 1 each 5000 5000
Total Shareholder funds
5000
5000

STATEMENTS

  1. For the year ending 31 December 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 December 2025

And signed on their behalf by:
Shudong XING, Director